Steven Cohen Bridge Bio Pharma, Inc. Transaction History
Point72 Asset Management, L.P.
- $42.2 Billion
- Q4 2024
A detailed history of Steven Cohen (Point72 Asset Management, L.P.) transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Point72 Asset Management, L.P. holds 60,000 shares of BBIO stock, worth $2.23 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60,000
Previous 35,000
71.43%
Holding current value
$2.23 Million
Previous $891,000
84.74%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding BBIO
# of Institutions
320Shares Held
176MCall Options Held
13MPut Options Held
2.48M-
Kohlberg Kravis Roberts & Co. L.P. New York, NY25.3MShares$940 Million44.98% of portfolio
-
Viking Global Investors LP25.1MShares$935 Million2.33% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$561 Million0.01% of portfolio
-
Black Rock Inc. New York, NY12.4MShares$463 Million0.01% of portfolio
-
State Street Corp Boston, MA6.18MShares$230 Million0.01% of portfolio
About BridgeBio Pharma, Inc.
- Ticker BBIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 148,246,000
- Market Cap $5.52B
- Description
- BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...